Letter: tenofovir may be superior to entecavir for treatment-naive chronic hepatitis B patients

被引：2
|
作者：
Wang, Ji-Gan [1 ]
Chen, Rui [1 ]
Wang, Li-Chuan [1 ]
机构：
[1] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Nanning, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 09期
关键词：
HEPATOCELLULAR-CARCINOMA; VIRAL LOAD; MORTALITY; RISK; HBV;
D O I：
10.1111/apt.16323
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1048 / 1049
页数：2
相关论文
共 50 条
  • [21] PARTIAL VIROLOGICAL RESPONSE TO ENTECAVIR IN TREATMENT-NAiVE CHRONIC HEPATITIS B
    Kim, Seung Up
    Chon, Young Eun
    Lee, Chun Kyon
    Heo, Jeong
    Kim, Ja Kyung
    Yoon, Ki Tae
    Cho, Mong
    Lee, Kwan Sik
    Kim, Dong Hwan
    Choi, Eun Hee
    Park, Jun Yong
    Kim, Do Young
    Chon, Chae Yoon
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    HEPATOLOGY, 2010, 52 (04) : 501A - 502A
  • [22] Risk of hepatocellular carcinoma in treatment-naive chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States
    Kim, W. Ray
    Telep, Laura E.
    Jump, Belinda
    Lu, Mei
    Ramroth, Heribert
    Flaherty, John
    Gaggar, Anuj
    Chokkalingam, Anand P.
    Gordon, Stuart C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (07) : 828 - 835
  • [23] Letter: treatment of HBeAg plus chronic hepatitis B - is tenofovir truly superior to entecavir? Author's reply
    Gao, L.
    Trinh, H. N.
    Li, J.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) : 1339 - 1340
  • [24] CLINICAL OUTCOMES IN TENOFOVIR VERSUS ENTECAVIR TREATMENT FOR TREATMENT-NAIVE CHRONIC HEPATITIS B WITH COMPENSATORY CIRRHOSIS IN CHINA - AN INTERIM ANALYSIS
    Huang, Yan
    Gui, Honglian
    Chen, Lichang
    Wu, Chao
    Zhu, Chuanwu
    Shang, Jia
    Qian, Yunsong
    Lian, Jianqi
    Liu, Longgen
    Jiang, Jian Ning
    Liu, Chenghai
    Xie, Qing
    HEPATOLOGY, 2021, 74 : 473A - 473A
  • [25] Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients
    Buti, Maria
    Maria Morillas, Rosa
    Prieto, Martin
    Diago, Moises
    Perez, Juan
    Sola, Ricard
    Bonet, Lucia
    Palau, Antonio
    Testillano, Milagros
    Garcia-Samaniego, Javier
    Rodriguez, Manuel
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (05) : 535 - 542
  • [26] Long-term outcomes of entecavir monotherapy in patients with treatment-naive chronic hepatitis B
    Kim, Hyung Joon
    Lee, Hyun Woong
    Park, Ji Hoon
    Lee, Kyeong Heon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 248 - 249
  • [27] Efficacy of three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients
    Yang, S. Y.
    Kim, H. J.
    Lee, H. W.
    Cha, B. K.
    Song, I. D.
    Kim, S. W.
    Heo, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 159 - 159
  • [28] Efficacy of Real-world Entecavir Therapy in Treatment-naive Chronic Hepatitis B Patients
    Xie, Yan-Di
    Ma, Hui
    Feng, Ba
    Wei, Lai
    CHINESE MEDICAL JOURNAL, 2017, 130 (18) : 2190 - 2197
  • [29] OUTCOME OF 4-YEAR TREATMENT OF ENTECAVIR FOR TREATMENT-NAIVE CHRONIC HEPATITIS B
    Seto, W-K.
    Lai, C-L.
    Fung, J.
    Yuen, J. C-H.
    Wong, D. K-H.
    Yuen, M-F.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S301 - S301
  • [30] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive patients with chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2022, 77 : S842 - S842
12345